Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Dentsply Sirona Inc (NQ: XRAY )

18.79 +0.15 (+0.80%)
Streaming Delayed Price Updated: 1:55 PM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Dentsply Sirona Inc

< Previous 1 2 3 4 5 6 7 Next >
INVESTOR ALERT: Law Offices of Howard G. Smith Continues Its Investigation of Dentsply Sirona Inc. (XRAY) on Behalf of Investors
From Law Offices of Howard G. Smith
Via Business Wire
Dentsply Sirona's Q1 Earnings Miss Street Expectations, Cuts FY22 Guidance
Via Benzinga
The Law Offices of Frank R. Cruz Continues Its Investigation of Dentsply Sirona Inc. (XRAY) on Behalf of Investors
From The Law Offices of Frank R. Cruz
Via Business Wire
Recap: Dentsply Sirona Q1 Earnings
Dentsply Sirona (NASDAQ:XRAY) reported its Q1 earnings results on Tuesday, May 10, 2022 at 06:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Read Why HC Wainwright Cut Price Target For Dentsply Sirona
Via Benzinga
Earnings Scheduled For May 10, 2022
Companies Reporting Before The Bell • The Middleby (NASDAQ:MIDD) is expected to report quarterly earnings at $2.10 per share on revenue of $935.99 million. 
Via Benzinga
Ongoing Investigation Notice: The Schall Law Firm Encourages Investors in DENTSPLY SIRONA Inc. with Losses of $100,000 to Contact the Firm
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Ongoing Investigation Reminder: The Schall Law Firm Encourages Investors in DENTSPLY SIRONA Inc. with Losses of $100,000 to Contact the Firm
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Dentsply Sirona Q1 2022 Earnings Conference Call On May 10, 2022 At 08:30 AM ET
Dentsply Sirona (NASDAQ:XRAY) will host a conference call at 08:30 AM ET on May 10, 2022, to discuss Q1 2022 earnings results. 
Via Benzinga
Ongoing Investigation Alert: The Schall Law Firm Encourages Investors in DENTSPLY SIRONA Inc. with Losses of $100,000 to Contact the Firm
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Investigation Notice: The Schall Law Firm Encourages Investors in DENTSPLY SIRONA Inc. with Losses of $100,000 to Contact the Firm
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Dentsply Sirona Earnings Conference Call Is Coming Up, Here's What You Need To Know
Dentsply Sirona (NASDAQ:XRAY) will host a conference call at 08:30 AM ET on May 5, 2022, to discuss Q1 2022 earnings results. How to Attend Dentsply Sirona (XRAY) Conference Call Follow this link to... 
Via Benzinga
DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Shareholder Notice: Investigation over Possible Violations of Securities Laws
San Diego, CA -- (SBWIRE) -- 05/03/2022 -- DENTSPLY SIRONA Inc is under investigation on behalf of investors of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) shares over potential securities laws violations by... 
Via SBWire
INVESTIGATION REMINDER: The Schall Law Firm Encourages Investors in DENTSPLY SIRONA Inc. with Losses of $100,000 to Contact the Firm
From The Schall Law Firm
Via Business Wire
INVESTIGATION ALERT: The Schall Law Firm Encourages Investors in DENTSPLY SIRONA Inc. with Losses of $100,000 to Contact the Firm
From The Schall Law Firm
Via Business Wire
Stocks That Hit 52-Week Lows On Thursday
During Thursday, 849 stocks hit new 52-week lows. 
Via Benzinga
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Its Investigation of Dentsply Sirona Inc. (XRAY) on Behalf of Investors
From Glancy Prongay & Murray LLP
Via Business Wire
The Law Offices of Frank R. Cruz Continues Its Investigation of Dentsply Sirona Inc. (XRAY) on Behalf of Investors
From The Law Offices of Frank R. Cruz
Via Business Wire
Stocks That Hit 52-Week Lows On Monday
On Monday, 721 companies achieved new lows for the year. 
Via Benzinga
DENTSPLY ALERT: Bragar Eagel & Squire, P.C. is Investigating Dentsply Sirona, Inc. on Behalf of Dentsply Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
INVESTOR ALERT: Law Offices of Howard G. Smith Continues Its Investigation of Dentsply Sirona Inc. (XRAY) on Behalf of Investors
From Law Offices of Howard G. Smith
Via Business Wire
10 Biggest Price Target Changes For Friday
Keybanc cut Generac Holdings Inc. (NYSE: GNRC) price target from $435 to $350. Generac Holdings shares rose 0.4% to $241.99 in pre-market trading. 
Via Benzinga
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Dentsply Sirona Inc. (XRAY) on Behalf of Investors
From Glancy Prongay & Murray LLP
Via Business Wire
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Dentsply Sirona Inc. (XRAY) on Behalf of Investors
From Law Offices of Howard G. Smith
Via Business Wire
The Law Offices of Frank R. Cruz Announces Investigation of Dentsply Sirona Inc. (XRAY) on Behalf of Investors
From The Law Offices of Frank R. Cruz
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For April 20, 2022
Upgrades 
Via Benzinga
Expert Ratings for Dentsply Sirona
Over the past 3 months, 7 analysts have published their opinion on Dentsply Sirona (NASDAQ:XRAY) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a... 
Via Benzinga
10 Biggest Price Target Changes For Wednesday
Pivotal Research cut Netflix, Inc. (NASDAQ: NFLX) price target from $550 to $235. Netflix shares dipped 27% to $254.64 in pre-market trading. 
Via Benzinga
54 Biggest Movers From Yesterday
Gainers Checkmate Pharmaceuticals, Inc. (NASDAQ: CMPI) shares jumped 325.9% to close at $10.35 on Tuesday after Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) announced a deal to... 
Via Benzinga
Markets Rise Despite Another New 2-Year High For US 10-Year Treasury Note
U.S. indices traded higher Tuesday on continued volatility as traders assess Fed policy outlook, rising Treasury yields and quarterly earnings reports. Investors continued to... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.